range of organisms and cell types. Recently, CRISPR‐Cas–based diagnostic platform has
shown idealistic properties for pathogen detection. Integrating the CRISPR‐Cas platform
along with lateral flow system allows rapid, sensitive, specific, cheap, and reliable
diagnostic. It has the potential to be in frontline for not only pathogen detection during the
epidemic outbreak, but also cancer, and genetic diseases.